A new research paper was published in , Volume 16, on March 21, 2025, titled "NSD2-epigenomic reprogramming and maintenance of plasma cell phenotype in t(4;14) myeloma." ...

Researchers with City of Hope and MSK have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) ...

Our findings suggest a role for NSD2 in maintaining MM cell identity, with potential implications for future therapeutic ...

A lot of pictures with lucid details are beginning to emerge on the Nigerian political platform as the opposition to the ...

A new research paper was published in Oncotarget, Volume 16, on March 21, 2025, titled “NSD2-epigenomic reprogramming and ...

Cancer Center have created a tool that uses machine learning to assess a non-Hodgkin lymphoma (NHL) patient's likely response ...

It all starts when you finally arrive at the property, which is as off the grid as you can get in Israel. It’s somewhere near ...

GeneDx , a leader in delivering improved health outcomes through genomic insights, today announced the commercial expansion into Inborn Errors of Immunity (IEI), a group of nearly 500 genetic ...

Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT), a fully integrated, late-stage biotechnology company advancing a sustainable ...

JAMM AQUINO / JAQUINO @STARADVERTISER.COM Two checks totaling $10 million were presented Thursday at the state Capitol during a news conference announcing multimillion-dollar grants supporting cancer ...